Working... Menu
Trial record 44 of 10868 for:    Placebo AND once

Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03520972
Recruitment Status : Recruiting
First Posted : May 10, 2018
Last Update Posted : June 25, 2018
Tigermed Consulting Co., Ltd
Information provided by (Responsible Party):
PegBio Co., Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : March 31, 2019
  Estimated Study Completion Date : September 5, 2019